Alamar Biosciences: 10% owner Qiming Corporate sold 217,512 shares

What happened

• Qiming Corporate GP VI, Ltd., identified as a 10% owner, sold a total of 217,512 shares of Alamar Biosciences common stock in multiple open-market/private-sale transactions on Oct 19, 2026 and Oct 20, 2026. The filing reports total proceeds of $5,949,984.
• Breakdown in the filing:
  • Oct 19, 2026: 75,508 shares at a weighted average price of $26.34 for $1,988,881.
  • Oct 20, 2026: 142,004 shares in three weighted-average price groups:
    • 11,417 shares at $26.63 for $304,034.
    • 111,424 shares at $27.93 for $3,112,073.
    • 19,163 shares at $28.44 for $544,996.

Key details

• Transaction dates and prices: Oct 19, 2026 (weighted avg $26.34; range reported $26.20–$26.52 per footnote), Oct 20, 2026 (weighted avgs $26.63, $27.93, $28.44; ranges per footnotes: $26.20–$26.96, $27.28–$28.27, $28.28–$28.73).
• Shares owned after the transaction: not stated in the provided Form 4 excerpt.
• Relevant footnotes: the filing notes weighted-average prices and price ranges (footnotes F1, F6–F8) and identifies the record holders and Qiming Corporate's gp/general partner relationships and disclaimers of beneficial ownership for related funds (footnotes F2–F5). The reporting person offers to provide a detailed breakdown of sales by price on request.
• Filing timeliness: Form 4 filed Oct 21, 2026 covering transactions on Oct 19 and Oct 20, 2026; no late filing is indicated in the filing date and transaction dates.

Why it may matter

• The Form 4 reports open-market/private sales by a 10% owner (not an employee title) of a substantial block of shares totaling 217,512 shares and $5,949,984 in proceeds.
• The filing includes disclosures that certain sold shares are held of record by related funds for which Qiming Corporate serves as general partner or indirect general partner; Qiming Corporate disclaims beneficial ownership except to the extent of its pecuniary interest in those funds.
• A filing does not show why the insider traded or why the company acted.